Delivery Order SPE2DB22D2007-SPE2DB24FJ2UJ

Award Date 5/23/24
Potential Completion Date 5/24/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor, by the Defense Logistics Agency (DLA). The award is a $1,360.17 delivery order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued up to $999,999,999 through December 2025. The contract is for the delivery of Qsymia 7.5 mg-46 mg capsules, a prescription medication. This order does not have a set-aside designation. Amerisourcebergen, through its...
This federal contract award is for the delivery of the prescription drug Qsymia 3.75 mg-23 mg capsules, in 30-count packages, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,544.45 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp's Corporate Office division. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,608.40 firm-fixed-price delivery order is for the supply of Qsymia 7.5 mg-46 mg capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA for the delivery of a comprehensive range of medical commodities to support military treatment programs and facilities...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical drug QSYMIA 7.5 MG-46 MG CAPSULE 30S. The contract, valued at $1,466.24, was awarded by the Defense Logistics Agency (DLA) and is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
The U.S. government awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug QSYMIA 7.5MG-46MG 30S. The contract, valued at $1,663.14, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025, which serves as the...
This federal contract award (SPE2DB20D3303 | SPE2DB24FZ6U6) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,419.00 firm-fixed-price delivery order is for the supply of Qsymia 3.75 mg-23 mg capsules. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,463.52 firm-fixed price Delivery Order is for the supply of the prescription medication Qsymia 7.5 mg-46 mg capsules, with a completion date of June 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This single-award IDC...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product QSYMIA 7.5 MG-46 MG CAPSULE 30S. The contract, valued at $1,274.90, was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This is a federal contract award with a ceiling value of $6,117.60 from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Qsymia 7.5 mg-46 mg capsules, a medication used for weight management. The award is a delivery order under an Indefinite Delivery Contract (IDC) worth up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Qsymia 3.75 mg-23 mg capsules. The award is a Delivery Order valued at $3,452.88 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, as...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ2UJ
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, provides Qsymia 7.5 mg-46 mg capsules to the Defense Logistics Agency (DLA). The $1,245.70 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and the DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation. Amerisourcebergen, as a subsidiary of one of the largest pharmaceutical distribution companies globally, leverages its extensive supply chain to efficiently fulfill government contracts for critical medical commodities.

Generated 8/22/24, 3:37 PM